1249–1255. 10 Chłopkiewicz B, Wójtowicz M, Marczewska J, Prokopczyk D, Koziorowska J. Contribution of N-oxidation and OH radicals to mutagenesis of 2-chloro- pyridine in Salmonella typhimurium. Acta Biochim Pol 1993; 40: 57–59. 11 Edenharder R, Grünhage D. Free radical scavenging abilities of flavonoids as mechanism of protection against mutagenicity induced by tert-butyl hydro- peroxide or cumene hydroperoxide in Salmonella typhimurium TA102. Mutat Res 2003; 540: 1–18. 12 Grey CE, Adlercreutz P. Ability of antioxidants to prevent oxidative muta- tions in Salmonella typhimurium TA102. Mutat Res 2003; 527: 27–36. 13 Yoshida R, Oikawa S, Ogawa Y, et al. Mutagenicity of p-aminophenol in E. coli WP2uvrA/pKM101 and its relevance to oxidative DNA damage. Mutat Res 1998; 415: 139–150. 14 Akman SA, Doroshow JH, Burke TG, Dizdaroglu M. DNA base modifica- tions induced in isolated human chromatin by NADH dehydrogenase- catalyzed reduction of doxorubicin. Biochemistry 1992; 31: 3500–3506. 15 Dizdaroglu M, Olinski R, Doroshow JH, Akman SA. Modification of DNA bases in chromatin of intact target human cells by activated human poly- morphonuclear leukocytes. Cancer Res 1993; 53: 1269–1272. 16 Brennan RJ, Swoboda BE, Schiestl RH. Oxidative mutagens induce intrachromosomal recombination in yeast. Mutat Res 1994; 308: 159–167. 17 Arredondo M, Núñez MT. Iron and copper metabolism. Mol Aspects Med 2005; 26: 313–327. 18 Takami T, Sakaida I. Iron regulation by hepatocytes and free radicals. J Clin Biochem Nutr 2011; 48: 103–106. 19 Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 2003; 533: 153–171. 20 Carthew P, Nolan BM, Smith AG, Edwards RE. Iron promotes DEN initiated GST-P foci in rat liver. Carcinogenesis 1997; 18: 599–603. 21 Mizukami S, Ichimura R, Kemmochi S, et al. Tumor promotion by copper- overloading and its enhancement by excess iron accumulation involving oxidative stress responses in the early stage of a rat two-stage hepatocarcino- genesis model. Chem Biol Interact 2010; 185: 189–201. 22 Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic Biol Med 1996; 20: 553–566. 23 Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 1996; 46: 311–332. 24 Lutsenko S. Atp7b-/- mice as a model for studies of Wilson’s disease. Biochem Soc Trans 2008; 36: 1233–1238. 25 Schümann K, Classen HG, Dieter HH, et al. Hohenheim consensus workshop: copper. Eur J Clin Nutr 2002; 56: 469–483. 26 Abe M, Suzuki N, Yoshida M, et al. Possible carcinogenic risks of copper gluconate and their prevention by co-administered green tea catechins evaluated by a rat medium-term multi-organ carcinogenicity bioassay protocol. Food Chem Toxicol 2008; 46: 1760–1770. 27 Abe M, Usuda K, Hayashi S, et al. Carcinogenic risk of copper gluconate evaluated by a rat medium-term liver carcinogenicity bioassay protocol. Arch Toxicol 2008; 82: 563–571. 28 Ye J, Zhang X, Young HA, Mao Y, Shi X. Chromium(VI)-induced nuclear factor-kappa B activation in intact cells via free radical reactions. Carcino- genesis 1995; 16: 2401–2405. 29 Liu KJ, Shi X, Dalal NS. Synthesis of Cr(IV)-GSH, its identification and its free hydroxyl radical generation: a model compound for Cr(VI) carcinogenicity. Biochem Biophys Res Commun 1997; 235: 54–58. 30 Shi H, Hudson LG, Ding W, et al. Arsenite causes DNA damage in keratino- cytes via generation of hydroxyl radicals. Chem Res Toxicol 2004; 17: 871– 878. 31 Hojo Y, Okado A, Kawazoe S, Mizutani T. Direct evidence for in vivo hydroxyl radical generation in blood of mice after acute chromium(VI) intake: electron spin resonance spin-trapping investigation. Biol Trace Elem Res 2000; 76: 75–84. 32 Lansdown AB. Physiological and toxicological changes in the skin resulting from the action and interaction of metal ions. Crit Rev Toxicol 1995; 25: 397– 462. 33 Shi H, Shi X, Liu KJ. Oxidative mechanism of arsenic toxicity and carcino- genesis. Mol Cell Biochem 2004; 255: 67–78. 34 Ding M, Li JJ, Leonard SS, et al. Vanadate-induced activation of activator protein-1: role of reactive oxygen species. Carcinogenesis 1999; 20: 663–668. 35 Hickey RJ, Schoff EP, Clelland RC. Relationship between air pollution and certain chronic disease death rates. Multivariate statistical studies. Arch Environ Health 1967; 15: 728–738. 36 Kraus T, Raithel HJ, Schaller KH. Quantitation of manganese and vanadium 14 levels in the lung of “normal” and occupationally exposed persons. Zentralbl Hyg Umweltmed 1989; 188: 108–126. 37 Cohen MD, Klein CB, Costa M. Forward mutations and DNA-protein crosslinks induced by ammonium metavanadate in cultured mammalian cells. Mutat Res 1992; 269: 141–148. 38 Sheu CW, Rodriguez I, Lee JK. Proliferation and morphological transforma- tion of BALB/3T3 cells by a prolonged treatment with sodium orthovanadate. Food Chem Toxicol 1992; 30: 307–311. 39 Elliott BM, Dodd NJ, Elcombe CR. Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis 1986; 7: 795–799. 40 Bernstein LR, Colburn NH. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989; 244: 566–569. 41 Vogt PK, Bos TJ. jun: oncogene and transcription factor. Adv Cancer Res 1990; 55: 1–35. 42 Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell- proliferation and transformation. Biochim Biophys Acta 1991; 1072: 129–157. 43 Kessler DJ, Duyao MP, Spicer DB, Sonenshein GE. NF-κB-like factors mediate interleukin 1 induction of c-myc gene transcription in fibroblasts. J Exp Med 1992; 176: 787–792. 44 Ji L, Arcinas M, Boxer LM. NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt’s lymphoma. Mol Cell Biol 1994; 14: 7967–7974. 45 Holliday R. Recombination and meiosis. Philos Trans R Soc Lond B Biol Sci 1977; 277: 359–370. 46 Price A. The repair of ionising radiation-induced damage to DNA. Semin Cancer Biol 1993; 4: 61–71. 47 Plosky B, Samson L, Engelward BP, et al. Base excision repair and nucleotide excision repair contribute to the removal of N-methylpurines from active genes. DNA Repair (Amst) 2002; 1: 683–696. 48 Gudmundsdottir K, Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 2006; 25: 5864–5874. 49 Seviour EG, Lin SY. The DNA damage response: balancing the scale between cancer and ageing. Aging (Albany NY) 2010; 2: 900–907. 50 Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002; 297: 547–551. 51 Harrison JC, Haber JE. Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006; 40: 209–235. 52 Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28: 739–745. 53 Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem Res Toxicol 2008; 21: 28–44. 54 Arita A, Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009; 1: 222–228. 55 De Flora S. Threshold mechanisms and site specificity in chromium(VI) carcinogenesis. Carcinogenesis 2000; 21: 533–541. 56 Smith AH, Hopenhayn-Rich C, Bates MN, et al. Cancer risks from arsenic in drinking water. Environ Health Perspect 1992; 97: 259–267. 57 Stout MD, Herbert RA, Kissling GE, et al. Hexavalent chromium is carcino- genic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ Health Perspect 2009; 117: 716–722. 58 Cui X, Wakai T, Shirai Y, Hatakeyama K, Hirano S. Chronic oral exposure to inorganic arsenate interferes with methylation status of p16INK4a and RASSF1A and induces lung cancer in A/J mice. Toxicol Sci 2006; 91: 372–381. 59 Badwey JA, Karnovsky ML. Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 1980; 49: 695–726. 60 Clifford DP, Repine JE. Hydrogen peroxide mediated killing of bacteria. Mol Cell Biochem 1982; 49: 143–149. 61 Doroshow JH. Role of hydrogen peroxide and hydroxyl radical formation in the killing of Ehrlich tumor cells by anticancer quinones. Proc Natl Acad Sci USA 1986; 83: 4514–4518. 62 Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 2007; 130: 797–810. 63 Wlassoff WA, Albright CD, Sivashinski MS, Ivanova A, Appelbaum JG, Salganik RI. Hydrogen peroxide overproduced in breast cancer cells can serve as an anticancer prodrug generating apoptosis-stimulating hydroxyl rad- icals under the effect of tamoxifen-ferrocene conjugate. J Pharm Pharmacol 2007; 59: 1549–1553. doi: 10.3164/jcbn.11105 ©2012 JCBN